Your browser doesn't support javascript.
loading
Targeted release of budesonide in primary IgA nephropathy.
Hu, Yitong; Zhang, Yuemiao.
Affiliation
  • Hu Y; Renal Division, Department of Medicine, Peking University First Hospital, Beijing 100034, China; Institute of Nephrology, Peking University, Beijing, China; Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China; Peking University Health Science Center, Beijing, China.
  • Zhang Y; Renal Division, Department of Medicine, Peking University First Hospital, Beijing 100034, China; Institute of Nephrology, Peking University, Beijing, China; Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China. Electronic address: zhangyuemiao@bjmu.edu.cn.
Lancet ; 403(10446): 2785, 2024 Jun 29.
Article in En | MEDLINE | ID: mdl-38944524
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Budesonide / Glomerulonephritis, IGA Limits: Humans Language: En Journal: Lancet Year: 2024 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Budesonide / Glomerulonephritis, IGA Limits: Humans Language: En Journal: Lancet Year: 2024 Document type: Article Affiliation country: Country of publication: